# Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/dabrafenib-plus-trametinib-in-patients-with-previously-treated-brafv600e-mutant/

## Facts

| Field | Value |
| --- | --- |
| Author Names | David Planchard,Benjamin Besse,Harry J.M. Groen,Pierre-Jean Souquet,Élisabeth Quoix,Christina S. Baik,Fabrice Barlési,Tae Min Kim,Julien Mazières,Silvia Novello,James R. Rigas,Allison Upalawanna,Anthony M. D’Amelio,Pingkuan Zhang,Bijoyesh Mookerjee,Bruce E. Johnson |
| Citations | 883 |
| DOI | 10.1016/s1470-2045(16)30146-2 |
| Fields | Biochemistry, Genetics and Molecular Biology,Chemistry,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | http://hdl.handle.net/2318/1587523 |
| OpenAlex ID | https://openalex.org/W3164126191 |
| PMID | 27283860 |
| Type | article |
| Year | 2016 |

## Paper authors

- [David Planchard](https://scholariq.org/researchers/david-planchard/)
- [Julien Mazières](https://scholariq.org/researchers/julien-mazieres/)
- [Silvia Novello](https://scholariq.org/researchers/silvia-novello/)
- [Tae Min Kim](https://scholariq.org/researchers/tae-min-kim/)
- [Benjamin Besse](https://scholariq.org/researchers/benjamin-besse/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)

## Paper topics

- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Synthesis and biological activity](https://scholariq.org/topics/synthesis-and-biological-activity/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.